Have a feature idea you'd love to see implemented?
Let us know!
BPTH Bio-Path Holdings Inc
Price (delayed)
$1.07
Market cap
$2.73M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$16.67
Enterprise value
-$1.22M
Bio-Path is a biotechnology company developing DNAbilize®, a novel technology that has yielded a pipeline of RNAi nanoparticle drugs that can be administered with a simple intravenous infusion. Bio-Path's lead
Highlights
Bio-Path Holdings's debt has shrunk by 67% YoY and by 35% QoQ
Bio-Path Holdings's EPS has soared by 62% YoY and by 36% from the previous quarter
BPTH's equity has soared by 149% since the previous quarter but it has dropped by 74% year-on-year
The quick ratio has contracted by 45% YoY
Key stats
What are the main financial stats of BPTH
Market
Valuations
Earnings
Shares outstanding
2.55M
Market cap
$2.73M
Enterprise value
-$1.22M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.37
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$11.6M
EBITDA
-$11.43M
Free cash flow
-$8.86M
Per share
Balance sheet
Liquidity
EPS
-$16.67
Free cash flow per share
-$5.5
Book value per share
$0.78
Revenue per share
$0
TBVPS
$3.17
Total assets
$5.12M
Total liabilities
$3.83M
Debt
$55,000
Equity
$1.29M
Working capital
$2.01M
Debt to equity
0.04
Current ratio
1.67
Quick ratio
1.33
Net debt/EBITDA
0.35
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-306.7%
Return on equity
-2,842.4%
Return on invested capital
N/A
Return on capital employed
-550.1%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BPTH stock price
How has the Bio-Path Holdings stock price performed over time
Intraday
0%
1 week
0%
1 month
15.05%
1 year
-92.25%
YTD
-88.44%
QTD
17.6%
Financial performance
How have Bio-Path Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$13.04M
Net income
-$11.6M
Gross margin
N/A
Net margin
N/A
BPTH's net income is up by 32% year-on-year and by 17% since the previous quarter
The operating income is up by 24% year-on-year and by 8% since the previous quarter
Growth
What is Bio-Path Holdings's growth rate over time
Valuation
What is Bio-Path Holdings stock price valuation
P/E
N/A
P/B
1.37
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Bio-Path Holdings's EPS has soared by 62% YoY and by 36% from the previous quarter
BPTH's equity has soared by 149% since the previous quarter but it has dropped by 74% year-on-year
The stock's price to book (P/B) is 35% less than its 5-year quarterly average of 2.1
Efficiency
How efficient is Bio-Path Holdings business performance
The return on equity has dropped by 174% since the previous quarter
BPTH's return on assets has dropped by 135% year-on-year but it is up by 9% since the previous quarter
Dividends
What is BPTH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BPTH.
Financial health
How did Bio-Path Holdings financials performed over time
The total assets is 34% more than the total liabilities
The total assets has soared by 189% from the previous quarter but it has contracted by 22% YoY
Bio-Path Holdings's total liabilities has surged by 158% YoY but it has decreased by 13% QoQ
Bio-Path Holdings's debt is 96% lower than its equity
BPTH's equity has soared by 149% since the previous quarter but it has dropped by 74% year-on-year
Bio-Path Holdings's debt has shrunk by 67% YoY and by 35% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.